US$ 26.54
bpc-157 e tb-500 / 10mg Why researchers are paying attention
Description
Importantly, tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in people with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
The medication would be billed as: J2778 3 units x 363.979 = $1091.94 total reimbursement

StatPearls NCBI Bookshelf

The injection : administered into your deltoid (upper arm) or, occasionally, the upper outer hip, by a licensed nurse practitioner or trained medical assistant under nurse-practitioner supervision
